Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression
Thymic carcinoma is a relatively rare and aggressive thymic epithelial tumor. Herein, we report successful treatment of thymic carcinoma with pembrolizumab. A 68-year-old woman was admitted to our hospital for evaluation of chest pain. Chest computed tomography showed a mass in the anterior mediasti...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Karger Publishers
2018-10-01
|
| Col·lecció: | Case Reports in Oncology |
| Matèries: | |
| Accés en línia: | https://www.karger.com/Article/FullText/493187 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|